Related Experiment Videos
[Pivampicillin and ampicillin in experimental E. coli pyelonephritis]
Arzneimittel-Forschung
|February 1, 1975
Summary
Privampicillin demonstrated higher antimicrobial activity than ampicillin in a rat pyelonephritis model. This study highlights pivampicillin
Area of Science:
- Pharmacology
- Microbiology
- Nephrology
Background:
- Ascending pyelonephritis is a significant kidney infection often caused by E. coli.
- Antibiotic efficacy in treating pyelonephritis is crucial for patient outcomes.
- Ampicillin is a commonly used antibiotic, but resistance and efficacy can vary.
Purpose of the Study:
- To compare the antimicrobial activity of pivampicillin and ampicillin.
- To evaluate their efficacy in a rat model of acute ascending pyelonephritis.
- To determine the impact of different dosages on treatment outcomes.
Main Methods:
- An acute ascending pyelonephritis model was induced in rats using E. coli.
- Two groups of rats received different concentrations of pivampicillin and ampicillin.
- Bacterial counts in renal parenchyma and urine were used to assess antimicrobial activity.
Main Results:
- Pivampicillin showed higher antimicrobial activity compared to ampicillin in Group I (lower ampicillin dose).
- In Group II (higher ampicillin dose), the efficacy of ampicillin was observed to increase.
- Bacterial load reduction in renal parenchyma and urine was analyzed.
Conclusions:
- Pivampicillin exhibits potent antimicrobial activity against E. coli in a pyelonephritis model.
- Dosage adjustments can influence the efficacy of both pivampicillin and ampicillin.
- Further research may explore optimal dosing strategies for pivampicillin in treating kidney infections.